U.S. Markets open in 55 hrs, 49 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,309.92 | -154.48 | -1.48% |
| NASDAQ | 2,138.44 | -37.61 | -1.73% |
| S&P 500 | 1,091.49 | -19.14 | -1.72% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 1.10 09:30 AM EST | |
|---|---|---|
| Day High | 1.50 10:44 AM EST |
|
| Range | 0.40 |
| Volume | 8.82 M | |
|---|---|---|
| 30-Day Avg Vol | 2.44 M |
|
| Difference | 260.58% |
| Market Cap | 183.15 M | |
|---|---|---|
| Mkt Cap Chg | 23.89 M |
| Shares Out | 132.72 M | |
|---|---|---|
| % Shrs Traded | 6.65% | |
| 1yr EPS Est | -0.069 |
| 52-Wk Low | 0.26 | |
|---|---|---|
| 52-Wk High | 4.54 |
|
| Range | 4.28 |
| Prev Close | 1.20 11/25/09 | |
|---|---|---|
| Today's Open | 1.10 | |
| Change | -8.33% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 13.19 M |
| Revenue (LFY) | 265,000 | |
|---|---|---|
| Earnings (LFY) | -12.22 M | |
| Earnings (MRQ) | -2.44 M | |
| Next Earn Est | -0.019 | |
| Next Earnings | 03/15/2010 |
|
| EPS (TTM) | -0.12 | |
| 1yr EPS Growth | 46.92% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -20.00 | |
| PEG Ratio | — | |
| Return on Equity | -74.30 | |
| Beta | 1.02 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Targeting chronic viral diseases and immune disorders, Hemispherx Biopharma hopes to do a world of good with its RNA (ribonucleic acid) and other drugs. The company has acquired the rights to Alferon N, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.019 3/15/10 | — — |
—
—
|
| Last Quarter | -0.029 9/30/09 | -0.02 9/30/09 |
0.009
Beat
|
| 2 Quarters Ago | -0.031 6/30/09 | -0.04 6/30/09 |
-0.009
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 25,000.00 | 265,000.00 |
| Gross Profit | -260,000.00 | -533,000.00 |
| Operating Income | -2.46 M | -12.81 M |
| Net Income | -2.44 M | -12.22 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts